US EditionPublished • loading... • Updated
FDA Considering Allowing New Sunscreen Ingredient in U.S.
The FDA seeks public input on bemotrizinol, a UV filter used overseas that could enhance sunscreen protection in the U.S. by 2026, officials said.
- The FDA opened a public comment period on Dec. 12, to review bemotrizinol for U.S. sunscreens before a decision.
- Regulatory limits have left the U.S. without new filters for over two decades, and DSM Nutritional Products LLC submitted the request to add bemotrizinol under the FDA's GRASE framework.
- Dermatologists say bemotrizinol could boost UVA protection as FDA safety findings report low absorption and rare irritation, with Dr. Karen Murry calling it a welcome addition.
- If approved, bemotrizinol could appear in products as early as 2026, as the FDA considers it GRASE, potentially giving millions of Americans improved sunscreen options, health experts say.
- Broader availability would align U.S. products with overseas markets, as bemotrizinol offers broad UVA and UVB protection that may reduce skin cancer risk.
Insights by Ground AI
40 Articles
40 Articles
Coverage Details
Total News Sources40
Leaning Left5Leaning Right5Center12Last UpdatedBias Distribution54% Center
Bias Distribution
- 54% of the sources are Center
54% Center
L 23%
C 54%
R 23%
Factuality
To view factuality data please Upgrade to Premium
